Skip to main content

Table 2 Minimum inhibitory concentration (mic) and antibiotic susceptibility of P. aeruginosa

From: The potential activity of biosynthesized silver nanoparticles of Pseudomonas aeruginosa as an antibacterial agent against multidrug-resistant isolates from intensive care unit and anticancer agent

Antibiotics tested

Isolates MIC (mg/L)

MIC breakpoint (mg/L)

 ≤ 

R > 

β-lactams

 AMP

 ≥ 32

8

8

 CFZ

 ≥ 64

16

16

 CTR

 ≥ 64

1

1

 CAZ

 ≥ 64

1

4

 CFX

 ≥ 64

1

2

 CPM

 ≥ 64

1

4

β-lactam/

 AMS

 ≥ 32

8

8

β-lactamase inhibitor

 TZP

 ≥ 128

8

16

Carbapenems

 MEM

 ≥ 16

2

8

Aminoglycosides

 AMK

 ≥ 64

8

16

 GEN

 ≥ 16

2

4

 TOB

 ≥ 16

2

4

Quinolones

 CIP

 ≥ 4

0.06

0.06

 LEV

 ≥ 8

1

2

Others

 NIT

 ≥ 512

4

64

 SXT

 ≥ 320

2

4

  1. AMP, ampicillin; CFZ, cefazolin; CTR, ceftriaxone; CAZ, ceftazidime; CFX, cefoxitin; CPM, cefepime; AMS, ampicillin/sulbactam; TZP, 182 piperacillin/tazobactam; MEM, meropenem; AMK, amikacin; GEN, gentamicin; TOB, tobramycin; CIP, ciprofloxacin; LEV, levofloxacin; NIT, nitrofurantoin; SXT, Trimethoprim / Sulfamethoxazole